Synthesis and Pharmacological Properties of Silicon-Containing GPR81 and GPR109A Agonists
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthesis and Pharmacological Properties of Silicon-Containing GPR81 and GPR109A Agonists
Authors
Keywords
-
Journal
ChemMedChem
Volume 10, Issue 12, Pages 2063-2070
Publisher
Wiley
Online
2015-10-14
DOI
10.1002/cmdc.201500343
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Can Silicon Make an Excellent Drug Even Better? An in vitro and in vivo Head-to-Head Comparison between Loperamide and Its Silicon Analogue Sila-Loperamide
- (2015) Marcel Geyer et al. ChemMedChem
- Si- and C-Functional Organosilicon Building Blocks for Synthesis Based on 4-Silacyclohexan-1-ones Containing the Silicon Protecting Groups MOP (4-Methoxyphenyl), DMOP (2,6-Dimethoxyphenyl), or TMOP (2,4,6-Trimethoxyphenyl)
- (2015) Marcel Geyer et al. JOURNAL OF ORGANIC CHEMISTRY
- Invariom based electron density studies on the C/Si analogues haloperidol/sila-haloperidol and venlafaxine/sila-venlafaxine
- (2015) Peter Luger et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Synthesis and evaluation of (E)-2-(acrylamido)cyclohex-1-enecarboxylic acid derivatives as HCA1, HCA2, and HCA3 receptor agonists
- (2014) Olga Bobileva et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushing
- (2014) Taku Sakurai et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Synthesis of 4-Silacyclohexan-1-ones and (4-Silacyclohexan-1-yl)amines Containing the Silicon Protecting Groups MOP (4-Methoxyphenyl), DMOP (2,4-Dimethoxyphenyl), or TMOP (2,4,6-Trimethoxyphenyl): Versatile Si- and C-Functional Building Blocks for Synthesis
- (2014) Markus Fischer et al. ORGANOMETALLICS
- Electron densities of bexarotene and disila-bexarotene from invariom application: a comparative study
- (2013) Peter Luger et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Organosilicon Molecules with Medicinal Applications
- (2012) Annaliese K. Franz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Disila-analogues of the synthetic retinoids EC23 and TTNN: synthesis, structure and biological evaluation
- (2012) Josef B. G. Gluyas et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Identification of Hydroxybenzoic Acids as Selective Lactate Receptor (GPR81) Agonists with Antilipolytic Effects
- (2012) Curt A. Dvorak et al. ACS Medicinal Chemistry Letters
- High-Affinity, Selective σ Ligands of the 1,2,3,4-Tetrahydro-1,4′-silaspiro[naphthalene-1,4′-piperidine] Type: Syntheses, Structures, and Pharmacological Properties
- (2011) Reinhold Tacke et al. ChemMedChem
- Silicon Analogues of the Nonpeptidic GnRH Antagonist AG-045572: Syntheses, Crystal Structure Analyses, and Pharmacological Characterization
- (2011) Matthew J. Barnes et al. ChemMedChem
- ShelXle: a Qt graphical user interface forSHELXL
- (2011) Christian B. Hübschle et al. JOURNAL OF APPLIED CRYSTALLOGRAPHY
- Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
- (2011) Nicholas A. Meanwell JOURNAL OF MEDICINAL CHEMISTRY
- Sila-Trifluperidol, a Silicon Analogue of the Dopamine (D2) Receptor Antagonist Trifluperidol: Synthesis and Pharmacological Characterization
- (2010) Reinhold Tacke et al. ORGANOMETALLICS
- In Vitro Metabolism of Haloperidol and Sila-Haloperidol: New Metabolic Pathways Resulting from Carbon/Silicon Exchange
- (2009) T. Johansson et al. DRUG METABOLISM AND DISPOSITION
- Role of GPR81 in lactate-mediated reduction of adipose lipolysis
- (2008) Tian-Quan Cai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Lactate Inhibits Lipolysis in Fat Cells through Activation of an Orphan G-protein-coupled Receptor, GPR81
- (2008) Changlu Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sila-Haloperidol, a Silicon Analogue of the Dopamine (D2) Receptor Antagonist Haloperidol: Synthesis, Pharmacological Properties, and Metabolic Fate
- (2007) Reinhold Tacke et al. ChemMedChem
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started